European Healthtech startup funding raised during December 2021.
In December 2021, 58 European Healthtech companies raised a combined €1.0B across 58 funding rounds, up 238.7% versus December 2020. Czech Republic led by capital raised, and Verve Ventures was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Sotio Biotech | Other | Dec 2021 | €280M |
| Anaveon | Series B | Dec 2021 | €105M |
| Emergence Therapeutics | Other | Dec 2021 | €87M |
| Northsea Therapeutics | Other |
2 exits · €435M disclosed.
| BenevolentAI | IPO | Dec 2021 | €435M |
| Dec 2021 |
| €71M |
| ViCentra | Series C | Dec 2021 | €65M |
| Adendra Therapeutics | Series A | Dec 2021 | €47M |
| EyeD Pharma | Other | Dec 2021 | €45M |
| Depixus | Series A | Dec 2021 | €31M |
| Bokadirekt | Other | Dec 2021 | €29M |
| Celyad Oncology | Other | Dec 2021 | €29M |
| Kenbi | Series A | Dec 2021 | €24M |
| Dawn Health | Other | Dec 2021 | €22M |
| FineHeart | Series B | Dec 2021 | €21M |
| Midiagnostics | Debt | Dec 2021 | €20M |
| Brainomix | Series B | Dec 2021 | €19M |
